Publications
5808 Results
- Journal / Conference
- Blood 130:145; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), oral
- Year
- 2017
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/C10603
An Analysis of Maintenance Therapy and Post-Midostaurin Outcomes in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603/RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations
- Journal / Conference
- Blood 130:2580; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
- Year
- 2017
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/C10603
An Analysis of the Cumulative Incidence of Relapse (CIR) in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603 / RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations
- Journal / Conference
- Blood 130:467; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), oral presentation
- Year
- 2017
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/C10603
Prognostic impact of NPM1/FLT3-ITD genotypes from randomized patients treated within the RATIFY CALGB 10603 (Alliance) Study
- Journal / Conference
- Blood 2017 130:1301; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
- Year
- 2017
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S1203, SWOG-8600, SWOG-9031, SWOG-9333
Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival (“Potential Cure”) Over the Past Four Decades: Analysis SWOG Trial Data
- Journal / Conference
- Nature Reviews Clinical Oncology Jul;14(7):417-433, 2017
- Year
- 2017
- Research Committee(s)
- Myeloma
- PMID
- PMID28117417
- PMC
- PMC5828026
- Study Number(s)
- S0777
Proteasome inhibitors in cancer therapy [Review]
- Journal / Conference
- Bulletin of the American College of Surgeons October Volume 102, Issue 10, 2017
- Year
- 2017
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0820
Updates on S0820/PACES: Preventing adenomas of the colon with eflornithine and sulindac [Review]
- Journal / Conference
- New England Journal of Medicine Aug 3;377(5):454-464
- Year
- 2017
- Research Committee(s)
- Leukemia
- PMID
- PMID28644114
- PMC
- PMC5754190
- Study Number(s)
- CTSU/C10603
Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation
- Journal / Conference
- Annals of Surgery Oct;266(4):667-676
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID28657941; PMC5755619
Tumor biology and response to chemotherapy impact breast cancer-specific survival in node-positive breast cancer patients treated with neoadjuvant chemotherapy: long-term follow-up from ACOSOG Z1071 (Alliance)
- Journal / Conference
- Journal of Oncology Practice Oct;13(10):693-699
- Year
- 2017
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID28915075;
- PMC
- PMC5946710
Responding to patient requests for hastened death: physician aid in dying and the clinical oncologist
- Journal / Conference
- Blood 130:188;American Society of Hematology Annual Meeting (Dec 9-12, 2017, Atlanta, GA), oral
- Year
- 2017
- Research Committee(s)
- Lymphoma
- Study Number(s)
- CTSU/9177